Annabelle South

University College London — United Kingdom

Medicine · Health Sciences

12h-index546citations63works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS Research and Interventions(16), Ethics in Clinical Research(10), Meta-analysis and systematic reviews(9), HIV/AIDS Impact and Responses(8), HIV/AIDS drug development and treatment(7)

Publications63 total

Trial design and enrolment characteristics of LATA (Long-Acting Treatment in Adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen cabotegravir/ rilpivirine compared to daily oral therapy in virologically suppressed adolescents with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan Africa
Contemporary Clinical Trials·2026Open Access
The use of antibiotics commonly associated with antimicrobial resistance: a UK network cohort study using primary and hospital care data
2025Open Access
Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV
Antimicrobial Agents and Chemotherapy·2025Open Access
Preferences between three options for androgen deprivation therapy: a focus group study
British Journal of Urology·2025· 1 citedOpen Access
Second-Line Antiretroviral Therapy for Children Living with HIV in Africa
New England Journal of Medicine·2025· 12 citedOpen Access
Master protocol for a series of cohort-based randomized controlled trials to test tools to communicate research results to study participants and others with relevant lived experience: the SPIN-CLEAR Trials
Trials·2025· 2 citedOpen Access
Evaluation of person-centred outcome measures for use in clinical trials of tuberculosis therapeutics
2025Open Access
Sharing clinical trial results with participants: important, expected and possible
Trials·2025· 3 citedOpen Access
Clinicians in low‐ and middle‐income settings need better access to point‐of‐care haemoglobin tests for identifying and managing children and pregnant women with severe anaemia
Tropical Medicine & International Health·2025Open Access
Developing a knowledge transfer and exchange strategy for a clinical trials unit
Trials·2025· 1 citedOpen Access
Trial design and enrolment characteristics of LATA (Long-Acting Treatment in Adolescents): a randomised, open-label, non-inferiority, 96-week trialevaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen (CAB/RPV) compared to daily oral therapy (DTG based TDF or TAF with 3TC or FTC backbone) in virologically suppressed adolescents living with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan Africa
SSRN Electronic Journal·2025Open Access
Short-Cycle Therapy (Weekends-Off) on Dolutegravir-Based Antiretroviral Therapy in Adolescents Living with HIV (BREATHER Plus): A Randomised, Open-Label, 96-Week Non-Inferiority Trial
SSRN Electronic Journal·2025Open Access
Population Pharmacokinetics of Dolutegravir in African Children: Results From the CHAPAS-4 Trial
Journal of the Pediatric Infectious Diseases Society·2024· 1 citedOpen Access
The SHOW RESPECT adaptable framework of considerations for planning how to share trial results with participants, based on qualitative findings from trial participants and site staff
Trials·2024· 6 citedOpen Access
Hit it hard: qualitative patient perspectives on the optimisation of immune checkpoint inhibition
British Journal of Cancer·2024· 2 citedOpen Access
The SHOW RESPECT adaptable framework of considerations for planning how to share trial results with participants, based on qualitative findings from trial participants and site staff
Research Square (Research Square)·2024· 1 citedOpen Access
Second-line tenofovir alafenamide for children with HIV in Africa
2024· 3 citedOpen Access
CHAPAS-4 trial: second-line anchor drugs for children with HIV in Africa
2024· 5 citedOpen Access
Voluntariness of consent in paediatric HIV clinical trials: a mixed-methods, cross-sectional study of participants in the CHAPAS-4 and ODYSSEY trials in Uganda
BMJ Open·2024Open Access
The effectiveness of interventions to disseminate the results of non-commercial randomised clinical trials to healthcare professionals: a systematic review
Implementation Science·2024· 5 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Diana M. Gibb(13), Matthew R. Sydes(9), Alasdair Bamford(8), Mahesh Parmar(7), Cissy Kityo(7), Claire L. Vale(6), Katie Gillies(6), Anna Turkova(6), Victor Musiime(6), Kate Sturgeon(5), William J Cragg(5), Deborah Ford(5), Elizabeth C. George(5), Mutsa Bwakura‐Dangarembizi(5), Alexander J. Szubert(5), Katja Doerholt(5), Shafic Makumbi(5), Bec Hanley(4), Mitzy Gafos(4), Conor Tweed(4)